Pharmaron Beijing Co Ltd Class A 300759
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- CN¥41.60
- Day Range
- CN¥40.15–42.05
- 52-Week Range
- CN¥21.01–53.57
- Bid/Ask
- CN¥40.89 / CN¥40.90
- Shares Outstanding
- 1.84B
- Market Cap
- CN¥75.14B
- Volume/Avg
- 29M / 48M
Key Statistics
- Price/Earnings (Normalized)
- 44.47
- Price/Sales
- 4.65
- Dividend Yield (Trailing)
- 0.49%
- Dividend Yield (Forward)
- 0.49%
- Dividend Payment Schedule
- Jul
- Total Yield
- 0.49%
Company Profile
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry, and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Core
- Total Number of Employees
- 25,088
- Website
- https://www.pharmaron.com
Valuation
Metric | 300759 |
|---|---|
Price/Earnings (Normalized) | 44.47 |
Price/Book Value | 4.45 |
Price/Sales | 4.65 |
Price/Cash Flow | 27.64 |
Price/Earnings
300759
Financial Strength
Metric | 300759 |
|---|---|
Quick Ratio | 0.69 |
Current Ratio | 1.04 |
Interest Coverage | 11.25 |
Quick Ratio
300759
Profitability
Metric | 300759 |
|---|---|
Return on Assets (Normalized) | 5.91% |
Return on Equity (Normalized) | 10.62% |
Return on Invested Capital (Normalized) | 7.70% |
Return on Assets
300759
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|Q^@PX$f | LOCK|^&^s | $135B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|LvrL?X^ | LOCK|hnDXZ | $99B | |||
| Moderna Inc MRNA | LOCK|l!nJ&N! | LOCK|L# | $84B | |||
| argenx SE ADR ARGX | LOCK|Yrtc&> | LOCK|@!s | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|D@t&Vb | LOCK|<HR | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|^&z!f%Lt | LOCK|StkR | $31B | |||
| Incyte Corp INCY | LOCK|D&X!?? | LOCK|p%> | $24B | |||
| BioNTech SE ADR BNTX | LOCK|>sV#m<D | LOCK|<fM | $21B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|Jj?mx? | LOCK|V?zl | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|kQ%C!x> | LOCK|%J | $15B |